EFSA rejects Lactobacillus casei probiotic gut health claim
date:Jun 08, 2012
ro-intestinal microorganisms might be a beneficial physiological effect,it said.

Rejection redaction

The NDA found that in four studies no clear benefits were demonstrated. One 2002 study evaluatedL. caseinumbers in faeces after consumption; two studies investigated the effects ofL. caseiplus the anti-inflammatory drug mesalazine in reducing colon disease. A fourth studiedthe effect ofL. caseialone and in various combinations on,intestinal microbiota adhering to the sigmoid colon mucosa, on th
3/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/25 14:53